Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis

Journal of Autoimmunity

Volumn 35, Issue 1, 2010, Pages 33-44

  York, Nathan R ^a   Mendoza, Jason P ^a   Ortega, Sterling B ^a   Benagh, Andrew ^a   Tyler, Andrew F ^a   Firan, Mihail ^a   Karandikar, Nitin J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PERFORIN; RNA; GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; T CELL DEPLETION; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOTOXICITY; DISEASE MODEL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; REGULATORY T LYMPHOCYTE; SECRETION (PROCESS);

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GLYCOPROTEINS; HUMANS; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, REGULATORY; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN;

EID: 77953289016     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.01.003     Document Type: Article

References (59)

1. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005, 23:683-747.
2. Crawford M.P., Yan S.X., Ortega S.B., Mehta R.S., Hewitt R.E., Price D.A., et al. High prevalence of autoreactive, neuroantigen-specific CD8+T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 2004, 103:4222-4231.
3. Neumann H., Medana I.M., Bauer J., Lassmann H. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 2002, 25:313-319.
4. Skulina C., Schmidt S., Dornmair K., Babbe H., Roers A., Rajewsky K., et al. Multiple sclerosis: brain-infiltrating CD8+T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A 2004, 101:2428-2433.
5. Tennakoon D.K., Mehta R.S., Ortega S.B., Bhoj V., Racke M.K., Karandikar N.J. Therapeutic induction of regulatory, cytotoxic CD8+T cells in multiple sclerosis. J Immunol 2006, 176:7119-7129.
6. Babbe H., Roers A., Waisman A., Lassmann H., Goebels N., Hohlfeld R., et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000, 192:393-404.
7. Hauser S.L., Bhan A.K., Gilles F., Kemp M., Kerr C., Weiner H.L. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol 1986, 19:578-587.
8. Jacobsen M., Cepok S., Quak E., Happel M., Gaber R., Ziegler A., et al. Oligoclonal expansion of memory CD8+T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 2002, 125:538-550.
9. Junker A., Ivanidze J., Malotka J., Eiglmeier I., Lassmann H., Wekerle H., et al. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 2007, 130:2789-2799.
10. Monteiro J., Hingorani R., Pergolizzi R., Apatoff B., Gregersen P.K. Clonal dominance of CD8+T-cell in multiple sclerosis. Ann N Y Acad Sci 1995, 756:310-312.
11. Traugott U., Reinherz E.L., Raine C.S. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 1983, 219:308-310.
12. Woodroofe M.N., Bellamy A.S., Feldmann M., Davison A.N., Cuzner M.L. Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J Neurol Sci 1986, 74:135-152.
13. Ford M.L., Evavold B.D. Specificity, magnitude, and kinetics of MOG-specific CD8+T cell responses during experimental autoimmune encephalomyelitis. Eur J Immunol 2005, 35:76-85.
14. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med 2001, 194:669-676.
15. Ji Q., Goverman J. Experimental autoimmune encephalomyelitis mediated by CD8+T cells. Ann N Y Acad Sci 2007, 1103:157-166.
16. Koh D.R., Fung-Leung W.P., Ho A., Gray D., Acha-Orbea H., Mak T.W. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 1992, 256:1210-1213.
17. Sun D., Whitaker J.N., Huang Z., Liu D., Coleclough C., Wekerle H., et al. Myelin antigen-specific CD8+T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 2001, 166:7579-7587.
18. Jiang H., Zhang S.I., Pernis B. Role of CD8+T cells in murine experimental allergic encephalomyelitis. Science 1992, 256:1213-1215.
19. Linker R.A., Rott E., Hofstetter H.H., Hanke T., Toyka K.V., Gold R. EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses. Neurobiol Dis 2005, 19:218-228.
20. Najafian N., Chitnis T., Salama A.D., Zhu B., Benou C., Yuan X., et al. Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. J Clin Invest 2003, 112:1037-1048.
21. Bettini M., Rosenthal K., Evavold B.D. Pathogenic MOG-reactive CD8+T cells require MOG-reactive CD4+T cells for sustained CNS inflammation during chronic EAE. J Neuroimmunol 2009, 213:60-68.
22. Quah B.J., Warren H.S., Parish C.R. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2007, 2:2049-2056.
23. Biegler B.W., Yan S.X., Ortega S.B., Tennakoon D.K., Racke M.K., Karandikar N.J. Glatiramer acetate (GA) therapy induces a focused, oligoclonal CD8+T-cell repertoire in multiple sclerosis. J Neuroimmunol 2006, 180:159-171.
24. Miller SD, Karpus WJ, 2007. Experimental autoimmune encephalomyelitis in the mouse. Curr Protoc Immunol, Chapter 15: Unit 15 1.
25. Ingulli E. Tracing tolerance and immunity in vivo by CFSE-labeling of administered cells. Methods Mol Biol 2007, 380:365-376.
26. Gershon R.K., Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 1970, 18:723-737.
27. Cantor H., Shen F.W., Boyse E.A. Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J Exp Med 1976, 143. 1391-1340.
28. Chess L., Jiang H. Resurrecting CD8+ suppressor T cells. Nat Immunol 2004, 5:469-471.
29. Jiang H., Braunstein N.S., Yu B., Winchester R., Chess L. CD8+T cells control the TH phenotype of MBP-reactive CD4+T cells in EAE mice. Proc Natl Acad Sci U S A 2001, 98:6301-6306.
30. Karandikar N.J., Crawford M.P., Yan X., Ratts R.B., Brenchley J.M., Ambrozak D.R., et al. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis. J Clin Invest 2002, 109:641-649.
31. Sercarz E., Maverakis E., van den Elzen P., Madakamutil L., Kumar V. Seven surprises in the TCR-centred regulation of immune responsiveness in an autoimmune system. Novartis Found Symp 2003, 252:165-171. discussion 171-176, 203-210.
32. Zozulya A.L., Wiendl H. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation. Hum Immunol 2008, 69:797-804.
33. Gavin M., Rudensky A. Control of immune homeostasis by naturally arising regulatory CD4+T cells. Curr Opin Immunol 2003, 15:690-696.
34. Kohm A.P., Carpentier P.A., Miller S.D. Regulation of experimental autoimmune encephalomyelitis (EAE) by CD4+CD25+ regulatory T cells. Novartis Found Symp 2003, 252:45-52. discussion 52-54, 106-114.
35. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., et al. Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006, 212:8-27.
36. Shevach E.M. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006, 25:195-201.
37. Balashov K.E., Khoury S.J., Hafler D.A., Weiner H.L. Inhibition of T cell responses by activated human CD8+T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis. J Clin Invest 1995, 95:2711-2719.
38. Jiang H., Kashleva H., Xu L.X., Forman J., Flaherty L., Pernis B., et al. T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc Natl Acad Sci U S A 1998, 95:4533-4537.
39. Li J., Goldstein I., Glickman-Nir E., Jiang H., Chess L. Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E. J Immunol 2001, 167:3800-3808.
40. Sarantopoulos S., Lu L., Cantor H. Qa-1 restriction of CD8+ suppressor T cells. J Clin Invest 2004, 114:1218-1221.
41. Smith T.R., Kumar V. Revival of CD8+ Treg-mediated suppression. Trends Immunol 2008, 29:337-342.
42. Tang X., Maricic I., Purohit N., Bakamjian B., Reed-Loisel L.M., Beeston T., et al. Regulation of immunity by a novel population of Qa-1-restricted CD8alphaalpha+TCRalphabeta+T cells. J Immunol 2006, 177:7645-7655.
43. Jurewicz A., Biddison W.E., Antel J.P. MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J Immunol 1998, 160:3056-3059.
44. Niland B., Banki K., Biddison W.E., Perl A. CD8+T cell-mediated HLA-A*0201-restricted cytotoxicity to transaldolase peptide 168-176 in patients with multiple sclerosis. J Immunol 2005, 175:8365-8378.
45. Mars L.T., Bauer J., Gross D.A., Bucciarelli F., Firat H., Hudrisier D., et al. CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice. J Immunol 2007, 179:5090-5098.
46. Na S.Y., Cao Y., Toben C., Nitschke L., Stadelmann C., Gold R., et al. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Brain 2008, 131:2353-2365.
47. Saxena A., Bauer J., Scheikl T., Zappulla J., Audebert M., Desbois S., et al. Cutting edge: multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J Immunol 2008, 181:1617-1621.
48. Adorini L. Immunotherapeutic approaches in multiple sclerosis. J Neurol Sci 2004, 223:13-24.
49. Chu C.Q., Wittmer S., Dalton D.K. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J Exp Med 2000, 192:123-128.
50. Correale J., Villa A. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. J Neuroimmunol 2008, 195:121-134.
51. Duong T.T., Finkelman F.D., Singh B., Strejan G.H. Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J Neuroimmunol 1994, 53:101-107.
52. Duong T.T., St Louis J., Gilbert J.J., Finkelman F.D., Strejan G.H. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J Neuroimmunol 1992, 36:105-115.
53. Ferber I.A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 1996, 156:5-7.
54. Myers L., Croft M., Kwon B.S., Mittler R.S., Vella A.T. Peptide-specific CD8 T regulatory cells use IFN-gamma to elaborate TGF-beta-based suppression. J Immunol 2005, 174:7625-7632.
55. Mahic M., Henjum K., Yaqub S., Bjornbeth B.A., Torgersen K.M., Tasken K., et al. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation. Eur J Immunol 2008, 38:640-646.
56. Filaci G., Suciu-Foca N. CD8+T suppressor cells are back to the game: are they players in autoimmunity?. Autoimmun Rev 2002, 1:279-283.
57. Lee Y.H., Ishida Y., Rifa'i M., Shi Z., Isobe K., Suzuki H. Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis. J Immunol 2008, 180:825-832.
58. Zimring J.C., Kapp J.A. Identification and characterization of CD8+ suppressor T cells. Immunol Res 2004, 29:303-312.
59. Kumar V., Sercarz E. An integrative model of regulation centered on recognition of TCR peptide/MHC complexes. Immunol Rev 2001, 182:113-121.